Guangdong True Health Medical Technology Development Co., Ltd. (2697.HK)

No price history available.

Not enough data to calculate KvantraRank

Based on consensus from external analysts. Not Kvantra's opinion.

Guangdong True Health Medical Technology Development Co., Ltd. engages in in the research and development, manufacture and sale of surgical robots and disposables in the People's Republic of China and Hong Kong. The company offers products, such as percutaneous puncture surgery robots, includes TH-S1, TH-S, TH-S Pro and TH-SA; microwave ablation surgical robot for the treatment of liver and lung tumors; percutaneous microwave ablation surgical robot TH-X HMW approved for the treatment of liver tumors; AI-based 3D reconstruction software for medical imaging; and five additional product, including the TH-P series of compact percutaneous puncture surgical robots which are approved for lung and abdominal puncture, the MW150 microwave ablation device, the TH-X Cryo cryoablation robot, the TH-LS KI300 and TH-LS LU100 ex vivo organ preservation and assessment systems. The company was formerly known as True Health (Guangdong Hengqin) Medical Technology Co., Ltd. and changed its name to Guangdong True Health Medical Technology Development Co., Ltd. in October 2025. The company was incorporated in 2018 and is based in Zhuhai, China.

• Embla Medical hf.
• Butterfly Network, Inc.
• Novocure Ltd
• Inspire Medical Systems, Inc.
• Fukuda Denshi Co., Ltd.
• GN Store Nord A/S
• Shanghai MicroPort Endovascular MedTech Co., Ltd.
• Drägerwerk AG & Co. KGaA